Blackrock Health Sciences Trust (NYSE:BME) Coverage Initiated at Shore Capital

Shore Capital began coverage on shares of Blackrock Health Sciences Trust (NYSE:BME) in a research report report published on Friday morning, Stock Target Advisor reports. The brokerage issued a buy rating and a $429.00 price objective on the stock.

BME traded up $0.02 on Friday, reaching $39.13. The stock had a trading volume of 20,409 shares, compared to its average volume of 31,259. Blackrock Health Sciences Trust has a fifty-two week low of $32.00 and a fifty-two week high of $42.49. The firm has a 50-day moving average of $38.28 and a 200-day moving average of $38.12.

The company also recently announced a monthly dividend, which will be paid on Friday, November 29th. Shareholders of record on Friday, November 15th will be issued a $0.20 dividend. The ex-dividend date of this dividend is Thursday, November 14th. This represents a $2.40 dividend on an annualized basis and a yield of 6.13%.

A number of institutional investors and hedge funds have recently modified their holdings of BME. Mid Atlantic Financial Management Inc. ADV acquired a new position in Blackrock Health Sciences Trust in the 2nd quarter worth about $219,000. Doliver Advisors LP acquired a new position in Blackrock Health Sciences Trust in the 2nd quarter worth about $259,000. Cetera Advisors LLC acquired a new position in Blackrock Health Sciences Trust in the 3rd quarter worth about $348,000. Commonwealth Equity Services LLC increased its holdings in Blackrock Health Sciences Trust by 17.1% in the 2nd quarter. Commonwealth Equity Services LLC now owns 11,324 shares of the company’s stock worth $440,000 after purchasing an additional 1,653 shares in the last quarter. Finally, Janney Montgomery Scott LLC increased its holdings in Blackrock Health Sciences Trust by 2.1% in the 3rd quarter. Janney Montgomery Scott LLC now owns 14,445 shares of the company’s stock worth $553,000 after purchasing an additional 300 shares in the last quarter.

Blackrock Health Sciences Trust Company Profile

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.

Read More: How are the companies in the S&P 500 selected?

Receive News & Ratings for Blackrock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blackrock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.